Can coaching clinics curb the opioid crisis? new study tests a novel approach

NCT ID NCT04632238

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This study tested a coaching and training program for addiction clinics to help them better treat opioid use disorder. The program included training on tracking patient progress, using medications for opioid use disorder, and improving patient retention. Researchers worked with nearly 8,000 patients across multiple clinics to see if this approach could improve health outcomes and reduce overdoses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Metrics-driven quality improvement (MDQI) - training and coaching for clinic staff
What this could lead to
If successful, this could provide a proven coaching model to help addiction clinics improve patient care and recovery rates.
What could go wrong
This is an observational study focused on clinic-level changes, not a direct treatment. Results may not apply to all clinics or lead to individual patient benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Samaritan Daytop Village Harlem - Outpatient Program

    New York, New York, 10027, United States

  • Samaritan Queens - Jamaica IOP

    Jamaica, New York, 11435, United States

  • Samaritan Rockland - Outpatient Program

    Blauvelt, New York, 10913, United States

  • Upper Manhattan Addiction Treatment Services Program

    New York, New York, 10031, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.